OCN Cancer Treatment Modalities 3

Question 1

Which immune checkpoint inhibitor targets PD-1?

Accepted Answer

Pembrolizumab

Answer

Ipilimumab

Answer

Atezolizumab

Answer

Durvalumab

Question 2

A patient on a VEGFR tyrosine kinase inhibitor (TKI) develops hypertension. The nurse should recognize this as:

Accepted Answer

A predictable on-target side effect

Answer

An unrelated comorbidity

Answer

A sign of tumor lysis syndrome

Answer

An allergic reaction requiring discontinuation

Question 3

What is the term for giving chemotherapy before the primary surgical procedure to shrink a tumor?

Accepted Answer

Neoadjuvant therapy

Answer

Adjuvant therapy

Answer

Salvage therapy

Answer

Consolidation therapy

Question 4

Which of the following is the correct definition of brachytherapy?

Accepted Answer

Radioactive source placed inside or near the tumor

Answer

High-energy proton beam delivered externally

Answer

Systemic radiolabeled antibody therapy

Answer

Fractionated external beam radiation

Question 5

A nurse is preparing to administer rituximab infusion. Which pre-medication is typically given to reduce infusion reactions?

Accepted Answer

Acetaminophen and diphenhydramine

Answer

Ondansetron and dexamethasone only

Answer

Epinephrine and hydrocortisone

Answer

Lorazepam and morphine

Question 6

CAR-T cell therapy works by:

Accepted Answer

Genetically engineering patient T cells to recognize and kill cancer cells

Answer

Delivering radiation to tumor cells via antibodies

Answer

Blocking checkpoint proteins on T cells

Answer

Stimulating NK cells with cytokines